TW534815B - Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity - Google Patents

Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity Download PDF

Info

Publication number
TW534815B
TW534815B TW86115162A TW86115162A TW534815B TW 534815 B TW534815 B TW 534815B TW 86115162 A TW86115162 A TW 86115162A TW 86115162 A TW86115162 A TW 86115162A TW 534815 B TW534815 B TW 534815B
Authority
TW
Taiwan
Prior art keywords
protein
patent application
scope
composition
nucleic acid
Prior art date
Application number
TW86115162A
Other languages
English (en)
Chinese (zh)
Inventor
Victoria Marie Knepp
Steven J Prestrelski
Jessica G Smith
Manley T F Huang
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of TW534815B publication Critical patent/TW534815B/zh

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW86115162A 1996-10-16 1997-10-15 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity TW534815B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2816796P 1996-10-16 1996-10-16

Publications (1)

Publication Number Publication Date
TW534815B true TW534815B (en) 2003-06-01

Family

ID=27658092

Family Applications (1)

Application Number Title Priority Date Filing Date
TW86115162A TW534815B (en) 1996-10-16 1997-10-15 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity

Country Status (4)

Country Link
CO (1) CO4890853A1 (es)
MY (1) MY125597A (es)
TW (1) TW534815B (es)
ZA (1) ZA977959B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI745671B (zh) * 2013-03-15 2021-11-11 美商百歐維拉提夫治療公司 因子ｉｘ多肽調配物

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI745671B (zh) * 2013-03-15 2021-11-11 美商百歐維拉提夫治療公司 因子ｉｘ多肽調配物
TWI788044B (zh) * 2013-03-15 2022-12-21 美商百歐維拉提夫治療公司 因子ｉｘ多肽調配物
US11642398B2 (en) 2013-03-15 2023-05-09 Bioverativ Therapeutics Inc. Factor IX polypeptide formulations

Also Published As

Publication number Publication date
CO4890853A1 (es) 2000-02-28
ZA977959B (en) 1998-03-23
MY125597A (en) 2006-08-30

Similar Documents

Publication Publication Date Title
US6730328B2 (en) Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
JP4018133B2 (ja) ヒト成長ホルモン水性製剤
US9949924B2 (en) Methods and compositions for oral administration of protein and peptide therapeutic agents
US4855134A (en) Sustained-release preparation
JP6525987B2 (ja) インスリングルリジンの安定製剤
US20010031726A1 (en) Mixed buffer system for stabilizing polypeptide formulations
JPH07165613A (ja) 経鼻吸収薬物用キャリヤおよび生理活性ペプチド組成物
JPH10506912A (ja) 安定な、水性αインターフェロン溶液処方物
JPH05508616A (ja) 治療用エアロゾル剤
CA2295140A1 (en) Stable insulin formulations
EP0138216B1 (en) Sustained-release ifn preparation for parenteral administration
TWI243057B (en) Formulations for protection of peg-interferon alpha conjugates
JP2802488B2 (ja) 経鼻吸収用生理活性ペプチド組成物
JP2021185201A (ja) コラーゲン７組成物及びそれを用いる方法
WO2001041793A1 (fr) Formulation stable d'interferon en solution, son procede de preparation et ses applications
JPH07118164A (ja) 経鼻吸収薬物用キャリヤおよび生理活性ペプチド組成物
KR20080042045A (ko) 포유동물로의 인터페론 전달용 지질 구조물
Fujioka et al. Long-acting delivery system of interferon: IFN minipellet
JP3697460B2 (ja) Ｈｇｆ含有製剤
TW534815B (en) Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
BR112018016545B1 (pt) Formulação farmacêutica liofilizada e seu uso
KR20080043742A (ko) 포유동물에게 인슐린을 전달하기 위한 지질 구조물
EP1200115B9 (en) Multi-dose erythropoietin formulations
JP3904268B2 (ja) Ｈｇｆ医薬製剤
JPH06199681A (ja) 生理活性ペプチド組成物

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees